Citations (76)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Claire Bonfils, Donald R Walkinshaw, Jeffrey M Besterman, Xiang-Jiao Yang & Zuomei Li. (2008) Pharmacological inhibition of histone deacetylases for the treatment of cancer, neurodegenerative disorders and inflammatory diseases. Expert Opinion on Drug Discovery 3:9, pages 1041-1065.
Read now
Read now
Articles from other publishers (75)
Andrea Fuso. 2024. Epigenetics in Human Disease. Epigenetics in Human Disease
1177
1218
.
Suvankar Banerjee, Sandip Kumar BaidyaNilanjan Adhikari, Tarun Jha & Balaram Ghosh. (2023) Hydrazides as Potential HDAC Inhibitors: Structure-activity
Relationships and Biological Implications. Current Topics in Medicinal Chemistry 23:25, pages 2343-2372.
Crossref
Crossref
Qingmeng Zheng, Heng Wang, An Yan, Fangyuan Yin & Xiaomeng Qiao. (2023) DNA Methylation in Alcohol Use Disorder. International Journal of Molecular Sciences 24:12, pages 10130.
Crossref
Crossref
Giulia Sgueglia, Salvatore Longobardi, Domenico Valerio, Maria Rosaria Campitiello, Nicola Colacurci, Cinzia Di Pietro, Rosalia Battaglia, Thomas D’Hooghe, Lucia Altucci & Carmela Dell’Aversana. (2023) The impact of epigenetic landscape on ovarian cells in infertile older women undergoing IVF procedures. Clinical Epigenetics 15:1.
Crossref
Crossref
Jin-kun Xia, Xue-qian Qin, Lu Zhang, Shu-jun Liu, Xiao-lei Shi & Hao-zhen Ren. (2022) Roles and regulation of histone acetylation in hepatocellular carcinoma. Frontiers in Genetics 13.
Crossref
Crossref
Yanjia Shen, Ran Yang, Jiaying Zhao, Miao Chen, Shuhan Chen, Baixi Ji, Houzao Chen, Depei Liu, Li Li & Guanhua Du. (2022) The histone deacetylase inhibitor belinostat ameliorates experimental autoimmune encephalomyelitis in mice by inhibiting TLR2/MyD88 and HDAC3/ NF-κB p65-mediated neuroinflammation. Pharmacological Research 176, pages 105969.
Crossref
Crossref
Daniela Buonvicino, Giuseppe Ranieri & Alberto Chiarugi. (2021) Treatment with Non-specific HDAC Inhibitors Administered after Disease Onset does not Delay Evolution in a Mouse Model of Progressive Multiple Sclerosis. Neuroscience 465, pages 38-45.
Crossref
Crossref
Yuan Gao, Hang Zhang, Frédéric Lirussi, Carmen Garrido, Xiang-Yang Ye & Tian Xie. (2020) Dual inhibitors of histone deacetylases and other cancer-related targets: A pharmacological perspective. Biochemical Pharmacology 182, pages 114224.
Crossref
Crossref
Min Seob Kwak, Hun Hee Lee, Jae Myung Cha, Hyun Phil Shin, Jung Won Jeon & Jin Young Yoon. (2020) Novel candidate drugs in anti-tumor necrosis factor refractory Crohn’s diseases: in silico study for drug repositioning. Scientific Reports 10:1.
Crossref
Crossref
Mahmoud A. Senousy, Olfat G. Shaker, Noha H. Sayed, Nevine Fathy & Mona A. Kortam. (2020) LncRNA GAS5 and miR-137 Polymorphisms and Expression are Associated with Multiple Sclerosis Risk: Mechanistic Insights and Potential Clinical Impact. ACS Chemical Neuroscience 11:11, pages 1651-1660.
Crossref
Crossref
Surabhi Shukla & Babu L. Tekwani. (2020) Histone Deacetylases Inhibitors in Neurodegenerative Diseases, Neuroprotection and Neuronal Differentiation. Frontiers in Pharmacology 11.
Crossref
Crossref
Patricia Hamminger, Ramona Rica & Wilfried Ellmeier. 2020.
1
59
.
Mona Hashemian, Maryam Ghasemi-Kasman, Hadi Parsian & Farzin Sadeghi. (2019) Fingolimod (FTY720) improves the functional recovery and myelin preservation of the optic pathway in focal demyelination model of rat optic chiasm. Brain Research Bulletin 153, pages 109-121.
Crossref
Crossref
Ramazan Rezaei, Saeed Aslani & Mahdi Mahmoudi. 2019. Pharmacoepigenetics. Pharmacoepigenetics
573
586
.
Subramaniam Sriram, Guzel Shaginurova, John T. Tossberg, Chandramohan Natarajan, Charles F. Spurlock & Thomas M. Aune. (2018) Longitudinal changes in the expression of IL-33 and IL-33 regulated genes in relapsing remitting MS. PLOS ONE 13:12, pages e0208755.
Crossref
Crossref
Hui He, Zhiping Hu, Han Xiao, Fangfang Zhou & Binbin Yang. (2018) The tale of histone modifications and its role in multiple sclerosis. Human Genomics 12:1.
Crossref
Crossref
Matthew Neal & Jason R. Richardson. (2018) Epigenetic regulation of astrocyte function in neuroinflammation and neurodegeneration. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 1864:2, pages 432-443.
Crossref
Crossref
Andrea Fuso. 2018. Epigenetics in Human Disease. Epigenetics in Human Disease
935
973
.
Patricia Aznar, Teresa Ayuso & Maite Mendióroz. 2018. The Epigenetics of Autoimmunity. The Epigenetics of Autoimmunity
167
186
.
Yanna Wu, Shanshan Ma, Yong Xia, Yangpeng Lu, Shiyin Xiao, Yali Cao, Sidian Zhuang, Xiangpeng Tan, Qiang Fu, Longchang Xie, Zhiming Li & Zhongmin Yuan. (2017) Loss of GCN5 leads to increased neuronal apoptosis by upregulating E2F1- and Egr-1-dependent BH3-only protein Bim. Cell Death & Disease 8:1, pages e2570-e2570.
Crossref
Crossref
Yu Ling, Sahar Alshareef, Haroon Butt, Jorge Lozano‐Juste, Lixin Li, Aya A. Galal, Ahmed Moustafa, Afaque A. Momin, Manal Tashkandi, Dale N. Richardson, Hiroaki Fujii, Stefan Arold, Pedro L. Rodriguez, Paula Duque & Magdy M. Mahfouz. (2017)
Pre‐
mRNA
splicing repression triggers abiotic stress signaling in plants
. The Plant Journal 89:2, pages 291-309.
Crossref
Crossref
Zi-jun Gao, Jie Min, Xu-cai Wu, Tian Yang, Chang-you Yan, Bu-huai Dong & Tao Zhang. (2016) Repression of neuronal nitric oxide (nNOS) synthesis by MTA1 is involved in oxidative stress-induced neuronal damage. Biochemical and Biophysical Research Communications 479:1, pages 40-47.
Crossref
Crossref
Marisela Agudelo, Gloria Figueroa, Tiyash Parira, Adriana Yndart, Karla Muñoz, Venkata Atluri, Thangavel Samikkannu & Madhavan P. Nair. (2016) Profile of Class I Histone Deacetylases (HDAC) by Human Dendritic Cells after Alcohol Consumption and In Vitro Alcohol Treatment and Their Implication in Oxidative Stress: Role of HDAC Inhibitors Trichostatin A and Mocetinostat. PLOS ONE 11:6, pages e0156421.
Crossref
Crossref
Cem İsmail Küçükali, Murat Kürtüncü, Arzu Çoban, Merve Çebi & Erdem Tüzün. (2014) Epigenetics of Multiple Sclerosis: An Updated Review. NeuroMolecular Medicine 17:2, pages 83-96.
Crossref
Crossref
Alvaro Martin, Cosmin A. Tegla, Cornelia D. Cudrici, Adam M. Kruszewski, Philippe Azimzadeh, Dallas Boodhoo, Armugam P. Mekala, Violeta Rus & Horea Rus. (2014) Role of SIRT1 in autoimmune demyelination and neurodegeneration. Immunologic Research 61:3, pages 187-197.
Crossref
Crossref
Nete Munk Nielsen, Henrik Svanström, Egon Stenager, Melinda Magyari, Nils Koch-Henriksen, Björn Pasternak & Anders Hviid. (2015) The use of valproic acid and multiple sclerosis. Pharmacoepidemiology and Drug Safety 24:3, pages 262-268.
Crossref
Crossref
Hui-Min Chen, Frederic L. Chedin, Christopher Chang & Patrick S.C. Leung. 2015. Epigenetics and Dermatology. Epigenetics and Dermatology
409
441
.
Fanglin Zhang, John T. Tossberg, Charles F. Spurlock, Song‐Yi Yao, Thomas M. Aune & Subramaniam Sriram. (2014)
Expression of
IL
‐33 and its epigenetic regulation in multiple sclerosis
. Annals of Clinical and Translational Neurology 1:5, pages 307-318.
Crossref
Crossref
Sergey Kalinin, Paul E. Polak, Shao Xia Lin, David Braun, Marina Guizzetti, Xiaolu Zhang, Israel Rubinstein & Douglas L. Feinstein. (2013) Dimethyl fumarate regulates histone deacetylase expression in astrocytes. Journal of Neuroimmunology 263:1-2, pages 13-19.
Crossref
Crossref
Gwenn A. Garden. (2013) Epigenetics and the Modulation of Neuroinflammation. Neurotherapeutics 10:4, pages 782-788.
Crossref
Crossref
Hidehiko Kikuchi, Masami Nakayama, Futoshi Kuribayashi, Shinobu Imajoh-Ohmi, Hideki Nishitoh, Yasunari Takami & Tatsuo Nakayama. (2014) GCN5 is essential for IRF-4 gene expression followed by transcriptional activation of Blimp-1 in immature B cells. Journal of Leukocyte Biology 95:3, pages 399-404.
Crossref
Crossref
Azam Jamshidian, Vahid Shaygannejad, Abbasali Pourazar, Sayyed-Hamid Zarkesh-Esfahani & Marjan Gharagozloo. (2013) Biased Treg/Th17 balance away from regulatory toward inflammatory phenotype in relapsed multiple sclerosis and its correlation with severity of symptoms. Journal of Neuroimmunology 262:1-2, pages 106-112.
Crossref
Crossref
Marcus W. Koch, Luanne M. Metz & Olga Kovalchuk. (2012) Epigenetic changes in patients with multiple sclerosis. Nature Reviews Neurology 9:1, pages 35-43.
Crossref
Crossref
Becky Inkster, Eva M.M. Strijbis, Maria Vounou, Ludwig Kappos, Ernst-Wilhelm Radue, Paul M. Matthews, Bernard M.J. Uitdehaag, Frederik Barkhof, Chris H. Polman, Giovanni Montana & Jeroen J.G. Geurts. (2013) Histone deacetylase gene variants predict brain volume changes in multiple sclerosis. Neurobiology of Aging 34:1, pages 238-247.
Crossref
Crossref
Marcus W. Koch, Luanne M. Metz & Olga Kovalchuk. (2013) Epigenetics and miRNAs in the diagnosis and treatment of multiple sclerosis. Trends in Molecular Medicine 19:1, pages 23-30.
Crossref
Crossref
Guohua Wang, Xiaoyan Jiang, Hongjian Pu, Wenting Zhang, Chengrui An, Xiaoming Hu, Anthony Kian-Fong Liou, Rehana K. Leak, Yanqin Gao & Jun Chen. (2012) Scriptaid, a Novel Histone Deacetylase Inhibitor, Protects Against Traumatic Brain Injury via Modulation of PTEN and AKT Pathway. Neurotherapeutics 10:1, pages 124-142.
Crossref
Crossref
Claudia Figueroa-Romero, Junguk Hur, Diane E. Bender, Colin E. Delaney, Michael D. Cataldo, Andrea L. Smith, Raymond Yung, Douglas M. Ruden, Brian C. Callaghan & Eva L. Feldman. (2012) Identification of Epigenetically Altered Genes in Sporadic Amyotrophic Lateral Sclerosis. PLoS ONE 7:12, pages e52672.
Crossref
Crossref
Hidehiko Kikuchi, Futoshi Kuribayashi, Shinobu Imajoh-Ohmi, Hideki Nishitoh, Yasunari Takami & Tatsuo Nakayama. (2012) GCN5 Protects Vertebrate Cells against UV-irradiation via Controlling Gene Expression of DNA Polymerase η. Journal of Biological Chemistry 287:47, pages 39842-39849.
Crossref
Crossref
Mario Bigioni, Alessandro Ettorre, Patrizia Felicetti, Sandro Mauro, Cristina Rossi, Carlo Alberto Maggi, Elena Marastoni, Monica Binaschi, Massimo Parlani & Daniela Fattori. (2012) Set-up of a new series of HDAC inhibitors: the 5,11-dihydrodibenzo[b,e]azepin-6-ones as privileged structures. Bioorganic & Medicinal Chemistry Letters 22:17, pages 5360-5362.
Crossref
Crossref
S. Y. Chai, R. Smith, T. Zakar, C. Mitchell & G. Madsen. (2012) Term myometrium is characterized by increased activating epigenetic modifications at the progesterone receptor-A promoter. Molecular Human Reproduction 18:8, pages 401-409.
Crossref
Crossref
P. Yuan, B. Chen, Y. Huang & X. Xin. (2012) Long-term regression of experimental endometriosis in a rat model treated with local application of levonorgestrel-loaded biodegradable microspheres. Human Reproduction 27:7, pages 2089-2095.
Crossref
Crossref
Andrea Fuso. 2012. Epigenetics in Human Disease. Epigenetics in Human Disease
519
544
.
Jian-Sheng Diao, Wen-Sen Xia, Cheng-Gang Yi, Ying-Mei Wang, Bing Li, Wei Xia, Bei Liu, Shu-Zhong Guo & Xu-De Sun. (2011) Trichostatin A inhibits collagen synthesis and induces apoptosis in keloid fibroblasts. Archives of Dermatological Research 303:8, pages 573-580.
Crossref
Crossref
K.E. May, J. Villar, S. Kirtley, S.H. Kennedy & C.M. Becker. (2011) Endometrial alterations in endometriosis: a systematic review of putative biomarkers. Human Reproduction Update 17:5, pages 637-653.
Crossref
Crossref
Y. Kawano, K. Nasu, H. Li, A. Tsuno, W. Abe, N. Takai & H. Narahara. (2011) Application of the histone deacetylase inhibitors for the treatment of endometriosis: histone modifications as pathogenesis and novel therapeutic target. Human Reproduction 26:9, pages 2486-2498.
Crossref
Crossref
Michael D. Shultz, Xueying Cao, Christine H. Chen, Young Shin Cho, Nicole R. Davis, Joe Eckman, Jianmei Fan, Alex Fekete, Brant Firestone, Julie Flynn, Jack Green, Joseph D. Growney, Mats Holmqvist, Meier Hsu, Daniel Jansson, Lei Jiang, Paul Kwon, Gang Liu, Franco Lombardo, Qiang Lu, Dyuti Majumdar, Christopher Meta, Lawrence Perez, Minying Pu, Tim Ramsey, Stacy Remiszewski, Suzanne Skolnik, Martin Traebert, Laszlo Urban, Vinita Uttamsingh, Ping Wang, Steven Whitebread, Lewis Whitehead, Yan Yan-Neale, Yung-Mae Yao, Liping Zhou & Peter Atadja. (2011) Optimization of the in Vitro Cardiac Safety of Hydroxamate-Based Histone Deacetylase Inhibitors. Journal of Medicinal Chemistry 54:13, pages 4752-4772.
Crossref
Crossref
Diego Mastroeni, Andrew Grover, Elaine Delvaux, Charisse Whiteside, Paul D. Coleman & Joseph Rogers. (2011) Epigenetic mechanisms in Alzheimer's disease. Neurobiology of Aging 32:7, pages 1161-1180.
Crossref
Crossref
Marisela Agudelo, Nimisha Gandhi, Zainulabedin Saiyed, Vijaya Pichili, Samikkannu Thangavel, Pradnya Khatavkar, Adriana Yndart-Arias & Madhavan Nair. (2011) Effects of Alcohol on Histone Deacetylase 2 (HDAC2) and the Neuroprotective Role of Trichostatin A (TSA). Alcoholism: Clinical and Experimental Research, pages no-no.
Crossref
Crossref
Giuseppe Faraco & Leonardo Cavone. (2011) . Molecular Medicine 17:5-6, pages 1.
Crossref
Crossref
P. Vercellini, P. Crosignani, E. Somigliana, P. Vigano, M. P. Frattaruolo & L. Fedele. (2010) 'Waiting for Godot': a commonsense approach to the medical treatment of endometriosis. Human Reproduction 26:1, pages 3-13.
Crossref
Crossref
Wayne W. Hancock. 2011. Histone Deacetylases: the Biology and Clinical Implication. Histone Deacetylases: the Biology and Clinical Implication
103
123
.
Nadine Chapman-Rothe & Robert Brown. 2011. Epigenetic Contributions in Autoimmune Disease. Epigenetic Contributions in Autoimmune Disease
150
161
.
Patrick O. McGowan, Michael J. Meaney & Moshe Szyf. 2011. Handbook of Behavior, Food and Nutrition. Handbook of Behavior, Food and Nutrition
17
31
.
Tae-Ho Kim, Jung-A Jung, Gun-Dong Kim, An-Hee Jang, Jeong-Je Cho, Yong Seek Park & Cheung-Seog Park. (2010) The histone deacetylase inhibitor, trichostatin A, inhibits the development of 2,4-dinitrofluorobenzene-induced dermatitis in NC/Nga mice. International Immunopharmacology 10:10, pages 1310-1315.
Crossref
Crossref
Moshe Szyf. (2009) Epigenetic Therapeutics in Autoimmune Disease. Clinical Reviews in Allergy & Immunology 39:1, pages 62-77.
Crossref
Crossref
Karen C. Dietz & Patrizia Casaccia. (2010) HDAC inhibitors and neurodegeneration: At the edge between protection and damage. Pharmacological Research 62:1, pages 11-17.
Crossref
Crossref
Y. Lu, J. Nie, X. Liu, Y. Zheng & S.-W. Guo. (2010) Trichostatin A, a histone deacetylase inhibitor, reduces lesion growth and hyperalgesia in experimentally induced endometriosis in mice. Human Reproduction 25:4, pages 1014-1025.
Crossref
Crossref
D.L. Miller, C.J.P. Jones, J.D. Aplin & L.G. Nardo. (2009) Altered glycosylation in peri-implantation phase endometrium in women with stages III and IV endometriosis. Human Reproduction 25:2, pages 406-411.
Crossref
Crossref
Go-Woon Kim, Goran Gocevski, Chao-Jung Wu & Xiang-Jiao Yang. (2010) Dietary, Metabolic, and Potentially Environmental Modulation of the Lysine Acetylation Machinery. International Journal of Cell Biology 2010, pages 1-14.
Crossref
Crossref
Giuseppe Faraco, Maria Pittelli, Leonardo Cavone, Silvia Fossati, Marco Porcu, Paolo Mascagni, Gianluca Fossati, Flavio Moroni & Alberto Chiarugi. (2009) Histone deacetylase (HDAC) inhibitors reduce the glial inflammatory response in vitro and in vivo. Neurobiology of Disease 36:2, pages 269-279.
Crossref
Crossref
S.-W. Guo. (2009) Epigenetics of endometriosis. Molecular Human Reproduction 15:10, pages 587-607.
Crossref
Crossref
Sandra J. Saouaf, Bin Li, Geng Zhang, Yuan Shen, Narumi Furuuchi, Wayne W. Hancock & Mark I. Greene. (2009) Deacetylase inhibition increases regulatory T cell function and decreases incidence and severity of collagen-induced arthritis. Experimental and Molecular Pathology 87:2, pages 99-104.
Crossref
Crossref
Natalia N. Nalivaeva, Nikolai D. Belyaev & Anthony J. Turner. (2009) Sodium valproate: an old drug with new roles. Trends in Pharmacological Sciences 30:10, pages 509-514.
Crossref
Crossref
Nicolas Fissolo, Sabrina Haag, Katrien L. de Graaf, Oliver Drews, Stefan Stevanovic, Hans Georg Rammensee & Robert Weissert. (2009) Naturally Presented Peptides on Major Histocompatibility Complex I and II Molecules Eluted from Central Nervous System of Multiple Sclerosis Patients. Molecular & Cellular Proteomics 8:9, pages 2090-2101.
Crossref
Crossref
Claudiu Komorowsky, Matthias Ocker & Margarete Goppelt‐Struebe. (2009) Differential regulation of connective tissue growth factor in renal cells by histone deacetylase inhibitors. Journal of Cellular and Molecular Medicine 13:8b, pages 2353-2364.
Crossref
Crossref
Alan P. Kozikowski, Yihua Chen, Tapadar Subhasish, Nancy E. Lewin, Peter M. Blumberg, Zhenyu Zhong, Melissa A. D'Annibale, Weng-Long Wang, Yong Shen & Brett Langley. (2009) Searching for Disease Modifiers-PKC Activation and HDAC Inhibition-A Dual Drug Approach to Alzheimer's Disease that Decreases Aβ Production while Blocking Oxidative Stress. ChemMedChem 4:7, pages 1095-1105.
Crossref
Crossref
S.-W. Guo. (2009) Recurrence of endometriosis and its control. Human Reproduction Update 15:4, pages 441-461.
Crossref
Crossref
M. W. Lawless, S. Norris, K. J. O’Byrne & S. G. Gray. (2009) Targeting histone deacetylases for the treatment of disease. Journal of Cellular and Molecular Medicine 13:5, pages 826-852.
Crossref
Crossref
Shue-Fen Luo, Chia-Chi Chang, I-Ta Lee, Chiang-Wen Lee, Wei-Ning Lin, Chih-Chung Lin & Chuen-Mao Yang. (2009) Activation of ROS/NF-κB and Ca2+/CaM kinase II are necessary for VCAM-1 induction in IL-1β-treated human tracheal smooth muscle cells. Toxicology and Applied Pharmacology 237:1, pages 8-21.
Crossref
Crossref
Hyejung Heo, Lang Yoo, Ki Soon Shin & Shin Jung Kang. (2009) Suppression of caspase-11 expression by histone deacetylase inhibitors. Biochemical and Biophysical Research Communications 378:1, pages 79-83.
Crossref
Crossref
B. Gellersen, M.S. Fernandes & J.J. Brosens. (2008) Non-genomic progesterone actions in female reproduction. Human Reproduction Update 15:1, pages 119-138.
Crossref
Crossref
Aleksey G. Kazantsev & Leslie M. Thompson. (2008) Therapeutic application of histone deacetylase inhibitors for central nervous system disorders. Nature Reviews Drug Discovery 7:10, pages 854-868.
Crossref
Crossref
Patrick O. McGowan, Michael J. Meaney & Moshe Szyf. (2008) Diet and the epigenetic (re)programming of phenotypic differences in behavior. Brain Research 1237, pages 12-24.
Crossref
Crossref
Christopher M. Reilly, Megan Thomas, Robert GogalJr.Jr., Selen Olgun, Arben Santo, Renna Sodhi, Eileen T. Samy, Stanford L. Peng, Gary S. Gilkeson & Nilamadhab Mishra. (2008) The histone deacetylase inhibitor trichostatin A upregulates regulatory T cells and modulates autoimmunity in NZB/W F1 mice. Journal of Autoimmunity 31:2, pages 123-130.
Crossref
Crossref
Andrea Brioschi, Gian Zara, Sara Calderoni, Maria Gasco & Alessandro Mauro. (2008) Cholesterylbutyrate Solid Lipid Nanoparticles as a Butyric Acid Prodrug. Molecules 13:2, pages 230-254.
Crossref
Crossref